Skip to main content

Advertisement

Log in

Des-γ-carboxy prothrombin stimulates human vascular endothelial cell growth and migration

  • Original Paper
  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Des-γ-carboxy prothrombin (DCP) is an aberrant prothrombin produced by hepatocellular carcinoma (HCC) cells. Serum and tissue DCP expressions are thought to reflect the biological malignant potential of HCC. However, the role of DCP in the development of angiogenesis is not well understood. Herein, we report the effects of DCP on growth and migration of human vascular endothelial cells. DCP significantly stimulated the proliferation of HUVEC (ECV304) cells in a dose and time dependent manner, as measured by the MTT assay. A continuous rapid migration of ECV304 cells was observed in the presence of DCP measured by the scratch wound assay. The continuous rapid invasive activity, measured by transwell chamber assay also showed that DCP increased endothelial cells migration through the reconstituted extracellular matrix (Matrigel). Further, the tube formation of vascular endothelial cells on 3-D Matrigel showed an increased number of branch points of ECV304 cells induced by DCP in a dose dependent manner. The levels of vascular endothelial cell growth-related angiogenic factors and matrix metalloproteinase were also examined. DCP significantly stimulated the expression levels of epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF), and matrix metalloproteinase (MMP)-2 (latent and active). Together, these data suggest that DCP is a novel type of vascular endothelial growth factor that possesses potent mitogenic and migrative activities in angiogenesis of HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Abbreviations

HCC:

Hepatocellular carcinoma

DCP:

Des-γ-carboxy prothrombin

HUVEC:

Human umbilical vein vascular endothelial cell line

MTT:

3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide

PBS:

Phosphate buffered saline

EDTA:

Ethylenediamine tetraacetic acid

HEPES:

Hydroethyl piperazine-ethane sulfonic acid

ELISA:

Enzyme-link immunosorbent assay

EGFR:

Epidermal growth factor receptor

VEGF:

Vascular endothelial growth factor

MMPs:

Matrix metalloproteinase

ECM:

Extracellular matrix

HGF:

Hepatocyte growth factor

KDR:

Kinase insert domain receptor

MAPK:

Mitogen-activated protein kinase

TGF-β:

Transforming growth factor-β

References

  1. Liebman HA (1989) Isolation and characterization of a hepatoma-associated abnormal (des-gamma-carboxy) prothrombin. Cancer Res 49(23):6493–6497

    PubMed  CAS  Google Scholar 

  2. Kim do Y, Paik YH, Ahn SH et al (2007) PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection. Oncology 72(Suppl 1):52–57. doi:10.1159/000111707

    Article  PubMed  Google Scholar 

  3. Yuen MF, Lai CL (2005) Serological markers of liver cancer. Best Pract Res Clin Gastroenterol 19(1):91–99. doi:10.1016/j.bpg.2004.10.003

    Article  PubMed  CAS  Google Scholar 

  4. Naraki T, Kohno N, Saito H et al (2002) γ-Carboxyglutamic acid content of hepatocellular carcinoma-associated des-gamma-carboxy prothrombin. Biochim Biophys Acta 1586(3):287–298. doi:10.1016/S0925-4439(01)00107-7

    PubMed  CAS  Google Scholar 

  5. Suzuki M, Shiraha H, Fujikawa T et al (2005) Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma. J Biol Chem 280(8):6409–6415. doi:10.1074/jbc.M406714200

    Article  PubMed  CAS  Google Scholar 

  6. Gao FJ, Cui SX, Chen MH et al (2008) Des-gamma-carboxy prothrombin increases the expression of angiogenic factors in human hepatocellular carcinoma cells. Life Sci 83(23–24):815–820. doi:10.1016/j.lfs.2008.10.003

    Article  PubMed  CAS  Google Scholar 

  7. Pang RW, Joh JW, Johnson PJ et al (2008) Biology of hepatocellular carcinoma. Ann Surg Oncol 15(4):962–971. doi:10.1245/s10434-007-9730-z

    Article  PubMed  Google Scholar 

  8. Shirabe K, Itoh S, Yoshizumi T et al (2007) The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol 95(3):235–240. doi:10.1002/jso.20655

    Article  PubMed  CAS  Google Scholar 

  9. Kitai S, Kudo M, Minami Y et al (2008) A new prognostic staging system for hepatocellular carcinoma: value of the biomarker combined Japan integrated staging score. Intervirology 51(Suppl 1):86–94. doi:10.1159/000122599

    Article  PubMed  CAS  Google Scholar 

  10. Fujikawa T, Shiraha H, Ueda N et al (2007) Des-gamma-carboxyl prothrombin-promoted vascular endothelial cell proliferation and migration. J Biol Chem 282(12):8741–8748. doi:10.1074/jbc.M609358200

    Article  PubMed  CAS  Google Scholar 

  11. Liu J, Li X, Cheng YN et al (2007) Inhibition of human gastric carcinoma cell growth by treatment of N(3)-o-toluyl-fluorouracil as a precursor of 5-fluorouracil. Eur J Pharmacol 574(1):1–7. doi:10.1016/j.ejphar.2007.06.064

    Article  PubMed  CAS  Google Scholar 

  12. Dua P, Gude RP (2008) Pentoxifylline impedes migration in B16F10 melanoma by modulating Rho GTPase activity and actin organisation. Eur J Cancer 44(11):1587–1595. doi:10.1016/j.ejca.2008.04.009

    Article  PubMed  CAS  Google Scholar 

  13. Subarsky P, Hill RP (2008) Graded hypoxia modulates the invasive potential of HT1080 fibrosarcoma and MDA MB231 carcinoma cells. Clin Exp Metastasis 25(3):253–264. doi:10.1007/s10585-007-9139-x

    Article  PubMed  CAS  Google Scholar 

  14. Yue PY, Wong DY, Wu PK et al (2006) The angiosuppressive effects of 20(R)-ginsenoside Rg3. Biochem Pharmacol 72(4):437–445. doi:10.1016/j.bcp.2006.04.034

    Article  PubMed  CAS  Google Scholar 

  15. Park K, Kim YS, Lee GY et al (2007) Antiangiogenic effect of bile acid acylated heparin derivative. Pharm Res 24(1):176–185. doi:10.1007/s11095-006-9139-6

    Article  PubMed  CAS  Google Scholar 

  16. Okutucu B, Dincer A, Habib O et al (2007) Comparison of five methods for determination of total plasma protein concentration. J Biochem Biophys Methods 70(5):709–711. doi:10.1016/j.jbbm.2007.05.009

    Article  PubMed  CAS  Google Scholar 

  17. Li Z, Zhou Z, Donahue HJ (2008) Alterations in Cx43 and OB-cadherin affect breast cancer cell metastatic potential. Clin Exp Metastasis 25(3):265–272. doi:10.1007/s10585-007-9140-4

    Article  PubMed  CAS  Google Scholar 

  18. Uehara S, Gotoh K, Handa H et al (2005) Distribution of the heterogeneity of des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma. J Gastroenterol Hepatol 20(10):1545–1552. doi:10.1111/j.1440-1746.2005.03899.x

    Article  PubMed  CAS  Google Scholar 

  19. Sugino T, Yamaguchi T, Hoshi N et al (2008) Sinusoidal tumor angiogenesis is a key component in hepatocellular carcinoma metastasis. Clin Exp Metastasis 25(7):835–841. doi:10.1007/s10585-008-9199-6

    Article  PubMed  Google Scholar 

  20. Mojzis J, Varinska L, Mojzisova G et al (2008) Antiangiogenic effects of flavonoids and chalcones. Pharmacol Res 57(4):259–265. doi:10.1016/j.phrs.2008.02.005

    Article  PubMed  CAS  Google Scholar 

  21. Klagsbrun M, Moses MA (1999) Molecular angiogenesis. Chem Biol 6(8):R217–R224. doi:10.1016/S1074-5521(99)80081-7

    Article  PubMed  CAS  Google Scholar 

  22. Kemp LE, Mulloy B, Cherardi E (2006) Signalling by HGF/SF and Met: the role of heparan sulphate co-receptors. Biochem Soc Trans 34(Pt 3):414–417. doi:10.1042/BST0340414

    PubMed  CAS  Google Scholar 

  23. Moon WS, Park HS, Yu KH et al (2006) Expression of betacellulin and epidermal growth factor receptor in hepatocellular carcinoma: implications for angiogenesis. Hum Pathol 37(10):1324–1332. doi:10.1016/j.humpath.2006.04.022

    Article  PubMed  CAS  Google Scholar 

  24. Black PC, Dinney CP (2007) Bladder cancer angiogenesis and metastasis-translation from murine model to clinical trial. Cancer Metastasis Rev 26(3–4):623–634. doi:10.1007/s10555-007-9084-9

    Article  PubMed  Google Scholar 

  25. Zhu AX, Raymond E (2009) Early development of sunitinib in hepatocellular carcinoma. Expert Rev Anticancer Thera 9(1):143–150. doi:10.1586/14737140.9.1.143

    Article  CAS  Google Scholar 

  26. Desiderio MA (2007) Hepatocyte growth factor in invasive growth of carcinomas. Cell Mol Life Sci 64(11):1341–1354. doi:10.1007/s00018-007-7050-x

    Article  PubMed  CAS  Google Scholar 

  27. El-Obeid A, Hesselager G, Westermark B et al (2002) TGF-alpha-driven tumor growth is inhibited by an EGF receptor tyrosine kinase inhibitor. Biochem Biophys Res Commun 290(1):349–358. doi:10.1006/bbrc.2001.6210

    Article  PubMed  CAS  Google Scholar 

  28. Bellmunt J, Hussain M, Dinney CP (2003) Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family. Crit Rev Oncol Hematol 46:S85–S104. doi:10.1016/S1040-8428(03)00067-2

    Article  PubMed  Google Scholar 

  29. Petit AM, Rak J, Huang MC et al (1997) Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Am J Pathol 151(6):1523–1530

    PubMed  CAS  Google Scholar 

  30. Okano J, Matsumoto K, Nagahara T et al (2006) Gefitinib and the modulation of the signaling pathways downstream of epidermal growth factor receptor in human liver cancer cells. J Gastroenterol 41(2):166–176. doi:10.1007/s00535-005-1736-3

    Article  PubMed  CAS  Google Scholar 

  31. Matsuo M, Sakurai H, Koizumi K et al (2007) Curcumin inhibits the formation of capillary-like tubes by rat lymphatic endothelial cells. Cancer Lett 251:288–295. doi:10.1016/j.canlet.2006.11.027

    Article  PubMed  CAS  Google Scholar 

  32. Allen DL, TeiteIbaum DH, Kurachi K (2003) Growth factor stimulation of matrix metalloproteinase expression and myoblast migration and invasion in vitro. Am J Physiol Cell Physiol 284(4):C805–C815. doi:10.1152/ajpcell.00215.2002

    PubMed  CAS  Google Scholar 

  33. Kargozaran H, Yuan SY, Breslin JW et al (2007) A role for endothelial-derived matrix metalloproteinase-2 in breast cancer cell transmigration across the endothelial-basement membrane barrier. Clin Exp Metastasis 24(7):495–502. doi:10.1007/s10585-007-9086-6

    Article  PubMed  CAS  Google Scholar 

  34. Lai K, Conwav RM, Crouch R et al (2008) Expression and distribution of MMPs and TIMPs in human uveal melanoma. Exp Eye Res 86(6):936–941. doi:10.1016/j.exer.2008.03.010

    Article  PubMed  CAS  Google Scholar 

  35. Werner JA, Rathcke IO, Mandic R (2002) The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck. Clin Exp Metastasis 19(4):275–282. doi:10.1023/A:1015531319087

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This project was supported by the Natural Science Foundation of China, Shandong Provincial Foundation for Natural Science (Y2006C87) and Shandong University Student’s Innovation Program. This work was also supported in part by Grant-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan (20015009). We thank Dr M. D. Lloyd (University of Bath, U. K.) for critically reading this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xian-Jun Qu.

Additional information

S. Cui and X.-J. Qu contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, SB., Cheng, YN., Cui, SX. et al. Des-γ-carboxy prothrombin stimulates human vascular endothelial cell growth and migration. Clin Exp Metastasis 26, 469–477 (2009). https://doi.org/10.1007/s10585-009-9246-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10585-009-9246-y

Keywords

Navigation